Retatrutide

What Is Retatrutide?

Retatrutide is an investigational peptide that interacts with three important metabolic pathways: GLP-1, GIP and glucagon. Because it targets all three receptors at the same time, it is commonly known as a triple agonist.

Each of these pathways has a different role in metabolism. GLP-1 is involved in appetite, digestion and glucose regulation. GIP plays a role in insulin signaling and how nutrients are processed, while glucagon is involved in glucose regulation and energy metabolism.

This unique three-part mechanism has made Retatrutide an important compound in ongoing metabolic studies, including studies looking at body-weight regulation, glucose metabolism, insulin signaling, energy balance and lipid metabolism.

Retatrutide is still under investigation and is not currently an approved medication.

Quality & Testing

At Peptiq Labs, quality and transparency are a priority. Available analytical testing and product documentation can be viewed through our Lab Results section.

For research purposes only. Information provided by Peptiq Labs is for educational and informational purposes and is not intended as medical advice or instructions for human use.